FindTrial
Sign In

Utility of Homoeopathic Medicines on Anti CCP levels in Rheumatoid Arthritis Patients

Comparative Study of Rheumatoid Arthritis Nosode 200 and Rhus Toxicodendron 200 on reduction of Anti CCP in Rheumatoid Arthritis patients in 3 months - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083826
Enrollment
40
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Rheumatoid Arthritis Nosode 200: Rheumatoid Arthritis Nosode 200 will be prescribed as daily dose for 3 months Control Intervention1: Rhus Toxicodendron 200: Rhus Toxicodendron 200 will

Sponsors

Maharashtra University of Health Sciences Nashik
Lead Sponsor
Dr Sukumar J Magdum Foundation Jaysingpur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Rheumatoid Arthritis with ongoing medication unchanged for 3 months

Exclusion criteria

Exclusion criteria: 1. Pregnant women will not be included in this study. 2. Patients with 2 or more auto immune diseases like SLE, Thyroiditis.

Design outcomes

Primary

MeasureTime frame
Anti CCP Values will be evaluatedTimepoint: Anti CCP Values will be evaluated at base level and after 12 weeks—

Secondary

MeasureTime frame
Symptomatology of Rheumatoid ArthritisTimepoint: Disease symptoms will be analyzed every month for 3 months—

Countries

India

Contacts

Public ContactMiss Zakera Kalsekar

Late Mrs Housabai Homoeopathic Medical College and Hospital Nimshirgaon Dist Kolhapur

kalsekarzakera08@gmail.com7506369021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026